Mivacurium Chloride 4%
Generic Name: mivacurium chloride 4%
Dosage form: POWDER. Active ingredients: MIVACURIUM CHLORIDE (1 kg/kg). Category: BULK INGREDIENT.
Overview
Dosage form: POWDER. Active ingredients: MIVACURIUM CHLORIDE (1 kg/kg). Category: BULK INGREDIENT.
Dosage
Available as powder.
Related Medications
Cinacalcet Hydrochloride
cinacalcet hydrochloride
11 DESCRIPTION Sensipar tablets contain the hydrochloride salt of the active ingredient cinacalcet, a positive modulator of the calcium sensing receptor . The empirical formula for cinacalcet is C 22 H 22 F 3 N•HCl with a molecular weight of 393.9 g/mol (hydrochloride salt) and 357.4 g/mol (free base). It has one chiral center having an R-absolute configuration. The R-enantiomer is the more potent enantiomer and has been shown to be responsible for pharmacodynamic activity.
Sodium Phosphate, Dibasic, Anhydrous, Potassium Phosphate, Monobasic, And Sodium Phosphate, Monobasic, Monohydrate
sodium phosphate, dibasic, anhydrous, potassium phosphate, monobasic, and sodium phosphate, monobasic, monohydrate
DESCRIPTION Each tablet contains 852 mg dibasic sodium phosphate anhydrous, 155 mg monobasic potassium phosphate, and the equivalent of 130 mg monobasic sodium phosphate monohydrate. Each tablet yields approximately 250 mg of phosphorus, 298 mg of sodium (13.0 mEq) and 45 mg of potassium (1.1 mEq). The components of K-PHOS® NEUTRAL have the following chemical names and molecular formulae: Dibasic Sodium Phosphate, Anhydrous Molecular Formula: Na2HPO4, Molecular Weight: 141.96.
S-8-ethyl-8-hydroxy-2,3,5,8-tetrahydro-6-oxa-3-aza-cyclopenta Naphthalene-1,4,7-trione
s-8-ethyl-8-hydroxy-2,3,5,8-tetrahydro-6-oxa-3-aza-cyclopenta naphthalene-1,4,7-trione
Dosage form: POWDER. Active ingredients: 4-ETHYL-4-HYDROXY-7,8-DIHYDRO-1H-PYRANO(3,4-F)INDOLIZINE-3,6,10(4H)-TRIONE, (S)- (25 kg/25kg). Category: BULK INGREDIENT.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.